CDXS
Codexis, Inc.NASDAQHealthcare$1.82+4.60%ClosedMarket Cap: $165.4M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.38
P/S
2.44
EV/EBITDA
-6.46
DCF Value
$-4.15
FCF Yield
-13.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
79.5%
Operating Margin
-54.5%
Net Margin
-62.5%
ROE
-90.5%
ROA
-29.8%
ROIC
-30.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $38.9M | 81.7% | $14.0M | $9.6M | $0.11 | — |
| FY 2025 | $70.4M | 79.5% | $-38.3M | $-44.0M | $-0.50 | — |
| Q3 2025 | $8.6M | 71.3% | $-18.9M | $-19.6M | $-0.22 | — |
| Q2 2025 | $15.3M | 86.3% | $-12.9M | $-13.3M | $-0.16 | — |
| Q1 2025 | $7.5M | 63.8% | $-20.5M | $-20.7M | $-0.25 | — |
| Q4 2024 | $21.5M | 83.0% | $-7.3M | $-10.4M | $-0.13 | — |
| FY 2024 | $59.3M | 72.6% | $-58.5M | $-65.3M | $-0.89 | — |
| Q3 2024 | $12.8M | 66.4% | $-16.6M | $-20.6M | $-0.29 | — |
| Q2 2024 | $8.0M | 56.6% | $-22.7M | $-22.8M | $-0.32 | — |
| Q1 2024 | $17.1M | 64.2% | $-11.9M | $-11.5M | $-0.16 | — |
| Q4 2023 | $26.6M | 84.6% | $281.0K | $-7.2M | $-0.10 | — |
| FY 2023 | $70.1M | 81.7% | $-68.1M | $-76.2M | $-1.12 | — |